10969826

pubmed:Citation

9

The carotid bodies are sensitive to glucose in vitro and can be stimulated to cause hyperglycemia in vivo. The aim of this study was to determine if the carotid bodies are involved in basal glucoregulation or the counterregulatory response to an insulin-induced decrement in arterial glucose in vivo. Dogs were surgically prepared >16 days before the experiment. The carotid bodies and their associated nerves were removed (carotid body resected [CBR]) or left intact (Sham), and infusion and sampling catheters were implanted. Removal of carotid bodies was verified by the absence of a ventilatory response to NaCN. Experiments were performed in 18-h fasted conscious dogs and consisted of a tracer ([3-3H]glucose) equilibration period (-120 to -40 min), a basal period (-40 to 0 min), and an insulin infusion (1 mU x kg(-1) x min(-1)) period (0-150 min) during which glucose was infused as needed to clamp at mildly hypoglycemic (65 mg/dl) or euglycemic (105 mg/dl) levels. Basal (8 microU/ml) and clamp (40 microU/ml) insulin levels were similar in both groups. Basal arterial glucagon was reduced in CBR compared with Sham (30 + 2 vs. 40 +/- 2 pg/ml) and remained reduced in CBR during hypoglycemia (peak levels of 36 +/- 3 vs. 52 +/- 7 pg/ml). Cortisol levels were not significantly different between the 2 groups in the basal state, but were reduced during the hypoglycemic clamp in CBR. Catecholamine levels were not significantly different between the 2 groups in the basal and hypoglycemic periods. The glucose infusion rate required to clamp glucose at 65 mg/dl was 2.5-fold greater in CBR compared with Sham (4.0 +/- 0.4 vs. 1.6 +/- 0.4 mg x kg(-1) x min(-1)). Basal endogenous glucose appearance (R(a)) was equal in CBR and Sham (2.5 +/- 0.1 vs. 2.5 +/- 0.2 mg x kg(-1) x min(-1)). During the hypoglycemic clamp, insulin suppressed R(a) in CBR but not Sham (1.1 +/- 0.2 vs. 2.5 +/- 0.2 mg x kg(-1) x min(-1) during the last 30 min of the clamp), reflecting impaired counterregulation. Glucose disappearance (R(d)) in the basal state was similar in CBR and Sham, whereas it was elevated in CBR during the hypoglycemic clamp (4.8 +/- 0.1 vs. 3.9 +/- 0.1 mg x kg(-1) x min(-1) during the last 30 min of the clamp). R(d) was also elevated in euglycemic clamp studies, indicating an effect of carotid body resection independent of hypoglycemia. There were no other measured systematic endocrine or metabolic effects of carotid body resection during euglycemic clamps. In conclusion, we found that the carotid bodies (or receptors anatomically close by) play an important role in the insulin-induced counterregulatory response to mild hypoglycemia.

eng

AIM

MEDLINE

0012-1797

Print

NLM

1434-42

pubmed-meshheading:10969826-Animals, pubmed-meshheading:10969826-Blood Glucose, pubmed-meshheading:10969826-Blood Pressure, pubmed-meshheading:10969826-Carotid Body, pubmed-meshheading:10969826-Dogs, pubmed-meshheading:10969826-Epinephrine, pubmed-meshheading:10969826-Female, pubmed-meshheading:10969826-Glucagon, pubmed-meshheading:10969826-Glucose, pubmed-meshheading:10969826-Glucose Clamp Technique, pubmed-meshheading:10969826-Homeostasis, pubmed-meshheading:10969826-Hormones, pubmed-meshheading:10969826-Hydrocortisone, pubmed-meshheading:10969826-Hyperglycemia, pubmed-meshheading:10969826-Hypoglycemia, pubmed-meshheading:10969826-Infusions, Intravenous, pubmed-meshheading:10969826-Insulin, pubmed-meshheading:10969826-Male, pubmed-meshheading:10969826-Norepinephrine, pubmed-meshheading:10969826-Time Factors

Evidence that carotid bodies play an important role in glucoregulation in vivo.

Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't